Dadkhah, A.; Wicha, S.G.; Kröger, N.; Müller, A.; Pfaffendorf, C.; Riedner, M.; Badbaran, A.; Fehse, B.; Langebrake, C.
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation. Pharmaceutics 2022, 14, 1145.
https://doi.org/10.3390/pharmaceutics14061145
AMA Style
Dadkhah A, Wicha SG, Kröger N, Müller A, Pfaffendorf C, Riedner M, Badbaran A, Fehse B, Langebrake C.
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation. Pharmaceutics. 2022; 14(6):1145.
https://doi.org/10.3390/pharmaceutics14061145
Chicago/Turabian Style
Dadkhah, Adrin, Sebastian Georg Wicha, Nicolaus Kröger, Alexander Müller, Christoph Pfaffendorf, Maria Riedner, Anita Badbaran, Boris Fehse, and Claudia Langebrake.
2022. "Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation" Pharmaceutics 14, no. 6: 1145.
https://doi.org/10.3390/pharmaceutics14061145
APA Style
Dadkhah, A., Wicha, S. G., Kröger, N., Müller, A., Pfaffendorf, C., Riedner, M., Badbaran, A., Fehse, B., & Langebrake, C.
(2022). Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation. Pharmaceutics, 14(6), 1145.
https://doi.org/10.3390/pharmaceutics14061145